Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001493152-23-012905
Filing Date
2023-04-19
Accepted
2023-04-19 16:05:15
Documents
1
Effectiveness Date
2023-04-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 14311
  Complete submission text file 0001493152-23-012905.txt   15634
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-455082 | Film No.: 23830074
SIC: 2834 Pharmaceutical Preparations